Cyclopentylacetyl chloride
CAS: 1122-99-2
Rif. 3D-FC130386
| 1g | Fuori produzione | ||
| 2g | Fuori produzione | ||
| 5g | Fuori produzione | ||
| 10g | Fuori produzione | ||
| 500mg | Fuori produzione |
Informazioni sul prodotto
- cyclopentaneacetyl chloride
Cyclopentylacetyl chloride (CPC) is a compound that is used to treat metabolic disorders, such as hepatitis and diabetes. It has been shown to inhibit the activity of the NS3 protease in the liver and pancreas, which is involved in the degradation of proteins into amino acids. In addition, this molecule can be used to induce inflammation by binding to adenosine receptors. CPC has also been shown to have anti-inflammatory effects on bowel disease and inflammatory bowel disease. This drug can prevent or reduce diabetic neuropathy by blocking the cb2 receptor, which is important in immune responses. Furthermore, cyclopentylacetyl chloride has been found to have cardioprotective properties against coronary heart diseases and congestive heart failure because it acts as an antagonist of the cb2 receptor. This causes a decrease in inflammation and prevents cell death caused by coronary heart diseases. Cyclopentylacetyl chloride also inhibits cancer cell proliferation by blocking adenosine receptors.
